Skip to main content
TipRanks
Go Ultimate75% OFF

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) Financial Statements

0 Followers

Biofil Chemicals & Pharmaceuticals Ltd. Financial Overview

Biofil Chemicals & Pharmaceuticals Ltd.'s market cap is currently ₹506.60M. The company's EPS TTM is ₹0.30; its P/E ratio is 107.17; Biofil Chemicals & Pharmaceuticals Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 283.95M₹ 334.02M₹ 400.35M₹ 300.35M₹ 223.82M
Gross Profit₹ 10.37M₹ 20.91M₹ 25.28M₹ 25.63M₹ 28.66M
Operating Income₹ 3.77M₹ 4.68M₹ 4.17M₹ 7.39M₹ 9.05M
EBITDA₹ 37.32M₹ 11.53M₹ 13.06M₹ 12.65M₹ 14.83M
Net Income₹ 27.86M₹ 5.58M₹ 7.09M₹ 5.60M₹ 6.98M
Balance Sheet
Cash & Short-Term Investments₹ 33.26M₹ 2.55M₹ 22.84M₹ 377.00K₹ 1.45M
Total Assets₹ 428.48M₹ 509.60M₹ 470.83M₹ 314.06M₹ 187.32M
Total Debt₹ 30.20M₹ 4.71M₹ 4.39M₹ 5.22M₹ 4.65M
Net Debt₹ -3.06M₹ 3.39M₹ -18.45M₹ 4.85M₹ 3.20M
Total Liabilities₹ 212.84M₹ 321.79M₹ 288.80M₹ 141.04M₹ 18.95M
Stockholders' Equity₹ 215.64M₹ 187.82M₹ 182.03M₹ 173.01M₹ 168.38M
Cash Flow
Free Cash Flow₹ -8.15M₹ -20.24M₹ 23.71M₹ -1.22M₹ -2.90M
Operating Cash Flow₹ -6.15M₹ -19.24M₹ 23.94M₹ -1.12M₹ -2.20M
Investing Cash Flow₹ 11.37M₹ -1.00M₹ -229.00K₹ -106.00K₹ -699.00K
Financing Cash Flow₹ 25.49M₹ -45.00K₹ -1.25M₹ 151.00K₹ -58.00K

Currency in INR

Biofil Chemicals & Pharmaceuticals Ltd. Earnings and Revenue History

0150M300M450M0 %5 %10 %15 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

Biofil Chemicals & Pharmaceuticals Ltd. Liabilities to Assets

0200M400M600M0 %25 %50 %75 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Biofil Chemicals & Pharmaceuticals Ltd. Cash Flow

-30M-20M-10M010M20M30M2017201820192020202120222023202420252026OperatingInvestingFinancing

Biofil Chemicals & Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

-0.500.511.52Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27EPS EstimateBeatMiss